LONDON, May 7, 2013 /PRNewswire/ --
A new report by visiongain predicts that the global market for infusion pumps will reach $9.8bn in 2017. That revenue forecast and others appear in Infusion Pumps: Technology and Market 2013-2023 , published in April 2013. Visiongain is a business information provider based in London, UK.
Visiongain predicts that the infusion pumps market will grow steadily to 2023. The future of the infusion pumps market appears promising. There is significant potential for growth and investment, driven by the increasing demand for safer and cost-effective technologies.
The infusion pumps market is diverse in its technologies and its geographic distribution. The market is intensely competitive, with industry leaders retaining market share through continuous product innovation and aggressive pricing, while smaller players resort to product building in a bid to sustain revenues. Despite the market being dominated by a few large manufacturers, there are several small companies manufacturing niche and innovative products. Each company has employed unique market and positioning strategies in an effort to increase their market share in the global market place.
Rodrigo Gutierrez Gamboa, a healthcare industry analyst in visiongain, said: "The infusion pumps market is subject to rapid technological change and product innovation. Recent technological developments show great promise in making infusion pumps accessible to a wider range of patients, particularly wireless 'smart' pumps. Innovation efforts in this market have been focused on developing devices with advanced and practically useful features.
"The market will continue to be driven by patient demographics and the introduction of innovative technologies in the coming years. This is clearly evidenced by the myriad of devices reported to be in development and awaiting regulatory authorisation. The market will also experience increasing demand for technologies in the homecare sector. As the market evolves and novel pumps become available, an increasing number of patients will receive their care at home. This will reduce the frequency of hospital visits and help save costs.
"In recent years, the infusion pumps market has been restrained by several high profile recalls and safety concerns. High profile recalls in the US have raised concerns in the global market, preventing the market from achieving its full growth potential. However, regulatory authorities are now actively promoting improved regulation of infusion pumps, helping to maintain and deliver safety standards."
Visiongain's report gives revenue forecasts to 2023 at overall world market, submarket and national level. It forecasts world sales for the following segments:
- Insulin pumps
- Enteral feeding pumps
- Other infusion pumps (including PCA and chemotherapy pumps).
The study includes researching trends and forecasting revenues in leading national markets. Countries analysed are the US, Japan, Germany, France, the UK, Spain, Italy, India and China. The analysis also discusses opportunities and developments - technological and commercial.
Infusion Pumps: Technology and Market 2013-2023 adds to visiongain's range of analytical reports on industries and markets in healthcare.
For sample pages and further information concerning the visiongain report The global infusion pumps market will reach $9.8 billion in 2017 predicts new visiongain report please visit
For an executive summary please contact:
Email: Sara Peerun on email@example.com
Allied Medical Instruments
Center for Devices and Radiological Health (CDRH)
Centers for Medicare and Medicaid Service (CMS)
Central Drug Standard Control Organisation (CDSCO)
Coldman & Shurtleff Inc
Curlin Medical Inc
D. Medical Industries
Generex Biotechnology Corportation
Hanraj Nayyar Medical India
H.S Hospital Service S.P.A
International Diabetes Federation (IDF)
Japanese Ministry of Health, Labour and Walfare (MHLW)
Johnson and Johnson (J&J)
Juvenile Diabetes Reasearch Foundation
Medical Devices Regulations Forum (MDRF)
Medicines and Healthcare Products Regulatory Agency (MHRA)
Oregon Health & Science University
Q Core Medical
RMS Medical Products
Sansum Diabetes Research Institute
Sensile Medical AG
Spring Health Solutions
Summit Medical Products
Symbios Medical Products
Tandem Diabetes Care
Universal Medical Technologies Inc
University of California Santa Barbara
US Department of Health and Human Service
Vishal Surgical Equipment
Wells Johnson Company
Woo Young Medical
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Automotive and Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44-(0)207-336-6100.